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Abstract
 
Flt3 ligand (Flt3L) is a growth factor for hemopoietic progenitors and can promote the expan-
sion of both conventional dendritic cells (DCs) and plasmacytoid predendritic cells (p-preDCs).
The cells responding to Flt3L treatment and the precursors for the DCs and p-preDCs had not
been fully characterized. We examined different mouse bone marrow (BM) hemopoietic precur-
sor populations for the surface expression of Flt3 and tested them for early DC and p-preDC pre-
cursor activity. Most DC precursor activity, other than that given by multipotent hemopoietic
stem cells, was within the downstream precursors expressing Flt3. The majority of mouse BM
common lymphoid precursors expressed high levels of Flt3 and these were the most efficient
precursors of both DCs and p-preDCs. In contrast, only a small proportion of the common
myeloid precursors (CMPs) expressed Flt3, but the precursor activity for both DCs and p-preDCs
was within this minor Flt3
 
  
 
CMP fraction. The granulocyte and macrophage precursors and pro-B
cells did not express Flt3 and had no DC or p-preDC precursor activity. These findings dem-
onstrate that the early precursors for all DC subtypes are within the BM Flt3
 
  
 
precursor popu-
lations, regardless of their lymphoid or myeloid lineage orientation.
Key words: dendritic cells • plasmacytoid predendritic cells • Flt3 • bone marrow • 
hemopoietic progenitors
 
Introduction
 
The ligand for the receptor kinase fms-like tyrosine kinase
3 (Flt3L)
 
* 
 
is a growth factor for hemopoietic progenitors
(1–3). Early studies have shown that the receptor for this
growth factor, namely Flt3, is expressed by a restricted sub-
set of early hemopoietic progenitors (4–7). Recent studies
have demonstrated that up-regulation of Flt3 expression
within the mouse BM Lin
 
  
 
Sca-1
 
  
 
c-kit
 
  
 
stem cell com-
partment is associated with the loss of self-renewal capac-
ity and sustained lymphoid-restricted potential (8). More-
over, these Flt3
 
  
 
Lin
 
  
 
Sca-1
 
  
 
c-kit
 
  
 
cells were shown to
serve as the precursors of BM common lymphoid precur-
sors (CLPs). Based on these findings, it was suggested that
Flt3 expression could be used as a marker to distinguish
the short-term reconstituting hemopoietic progenitors
from the long-term multipotent hemopoietic stem cells
(HSCs; 9).
Recently, the importance of Flt3L in the development
of DCs and plasmacytoid predendritic cells (p-preDCs) has
been recognized. Mice treated with Flt3L showed dramatic
increase in numbers of DCs and p-preDCs in blood and
lymphoid tissues (10–16). In addition, mice lacking Flt3L
showed deficiency not only in hemopoietic progenitor
cells, but also in DCs and natural killer cells (17). Flt3L has
been shown to promote the development of DCs in cul-
ture, especially from lymphoid precursors (18, 19). Recent
studies have also shown that the addition of Flt3L can pro-
mote the growth of large number of p-preDCs from
mouse BM cultures (20, 21). All above evidence supports
an important role of FLt3L in the development of DCs
and p-preDCs. It is not clear, however, at which stage of
DC and p-preDC development and on what precursor
cells Flt3L exerts its function.
Whether conventional DCs and the p-preDCs have a
related origin is not clear. Mouse p-preDCs have only been
identified recently (16, 22–26). Like their human counter-
part, mouse p-preDCs produce large amount of type I
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Abbreviations used in this paper:
 
 APC, allophycocyanin; CLP, common
lymphoid precursor; CMP, common myeloid precursor; Flt3L, Flt3
ligand; GMP, granulocyte and macrophage precursor; HSC, hemopoietic
stem cell; p-preDC, plasmacytoid predendritic cell.T
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IFNs upon stimulation by viruses or microbial stimuli, such
as CpG (16, 22–24, 26). Also, like their human counter-
part, mouse p-preDCs can produce DCs in culture, and
these DCs are of the CD8
 
  
 
type. However, despite this,
p-preDCs are not the normal precursors of CD8
 
  
 
conven-
tional DCs and apparently only produce DC progeny in
vivo on microbial infection (26). Nevertheless, it is gener-
ally assumed that DCs and p-preDCs have common pro-
genitors within the BM.
In this study we identified early precursors for mouse
DCs and p-preDCs in BM and thymus. Regardless of the
lymphoid or myeloid lineage orientation, the precursor ac-
tivity for DCs and p-preDCs is primarily associated with
those BM precursors showing surface expression of Flt3.
However, within the thymus there is evidence for a separa-
tion of the stream leading to the thymic CD8
 
  
 
DC and
thymic p-preDC because in contrast to BM CLPs, the early
T cell precursors can produce DCs but are very poor pre-
cursors of p-preDCs.
 
Materials and Methods
 
Mice.
 
C57BL/Ka-Thy-1.1 (Ly 5.2) mice at 6–7 wk of age
were used as donors. C57BL/6 Pep3b Ly 5.1 mice at 8–10 wk of
age were used as recipients. All mice were bred in the animal fa-
cility of The Walter and Eliza Hall Institute under specific patho-
gen-free conditions.
 
Antibodies.
 
The following monoclonal antibodies were used
as supernatants for immunomagnetic bead depletion of lineage
marker–positive BM cells: anti-CD3 (KT3-1.1), anti-CD8 (53-
6.7), anti-CD2 (RM2-1), anti-B220 (RA3-6B2), anti–Mac-1
(M1/70), anti–Gr-1 (RA6-8C5), and anti-erythrocyte antigen
(TER-119). The monoclonal antibody supernatants used for de-
pletion in splenic DC and splenic plasmacytoid cell preparations
were: anti-CD3 (KT3-1.1), anti-CD19 (ID3), anti-CD90 (T24/
31.7), anti–Gr-1 (RA6-8C5), and anti-erythrocyte antigen
(TER-119). For thymic DC and thymic plasmacytoid cell prepa-
ration, anti-CD11b (M1/70) and anti-macrophage antigen F4/80
(F4/80) were also added to the antibodies used for spleen prepa-
rations. Note that the use of anti–Gr-1 did not cause any deple-
tion of plasmacytoid cells in our mice (26).
The following purified antibodies were used as fluorescent
conjugates for cell staining and sorting: anti–Ly 5.2 (AL1-4A2)
used as an FITC conjugate; anti–Thy-1.1 (19XE5) used as an
FITC conjugate; anti–Fc
 
 
 
RII/III (anti–CD16/32[2.4G2]) used
as an FITC conjugate; anti-CD19 (ID3) used as an FITC conju-
gate; anti-Flt3 (A2F10.1) used as a PE conjugate; anti–c-kit (2B8)
used as an allophycocyanin (APC) conjugate; anti–Sca-1 (E13–
161–7) and anti–IL-7R
 
  
 
(A7R34) used as Alexa 594 conjugates;
and anti–IL-7R
 
  
 
(A7R34) and anti-CD34 (RAM34) used as bio-
tin conjugates. Anti–rat immunoglobulin–Texas Red and PE–
avidin were used for second stage staining. The following fluores-
cent conjugated antibodies were used for staining the DCs:
anti–MHC class II–FITC (M5/114), anti–CD11c–Alexa 594
(N418), anti–CD4-PE (GK1.5), anti–CD8-Cy5 (YTS 169.4),
and anti–DEC-205–biotin (NLDC-145) with PE-avidin used as
the second stage.
 
Isolation of Precursor Populations.
 
The early intrathymic lym-
phoid precursor population (CD3
 
  
 
CD8
 
  
 
CD4
 
low 
 
c-kit
 
  
 
CD25
 
 
 
Thy-1
 
low
 
) was purified by means of a previously described proce-
dure (27). The BM precursor populations were isolated by proce-
dures described elsewhere (28). In brief, the CLP population
from mouse BM was purified by immunomagnetic bead deple-
tion of lineage marker–positive cells, followed by enrichment
sorting for Sca-1
 
low/
 
  
 
cells. These enrichment-sorted cells were
stained with anti–Thy-1.1–FITC, anti–c-kit–APC, anti–Sca-1–
Alexa 594, and anti–IL-7R
 
 
 
–biotin, followed by PE-avidin as
the second stage. CLPs were then sorted as IL-7R
 
 
 
  
 
Sca-1
 
int
 
c-kit
 
int 
 
Thy-1.1
 
  
 
cells on a FACstar
 
PLUS
 
™ instrument (Becton
Dickinson). The myeloid-committed precursor populations from
BM were isolated by first depleting lineage marker–positive cells
by means of immunomagnetic beads. The remaining cells were
then stained with goat anti–rat immunoglobulin Texas Red and
anti–c-kit–APC and then enrichment sorted for lin
 
  
 
c-kit
 
  
 
cells.
The enrichment-sorted cells were then stained with anti-FcR
 
 
 
II/
III (CD16/32)–FITC, anti–c-kit–APC, anti–IL-7R
 
 
 
–Alexa 594,
anti–Sca-1–Alexa 594, and anti–CD34-biotin, followed by PE-
avidin. The common myeloid precursor (CMP) population was
sorted as CD16/32
 
low 
 
CD34
 
  
 
c-kit
 
  
 
Sca-1
 
  
 
IL-7R
 
 
 
  
 
cells. The
granulocyte and macrophage precursor (GMP) population was
sorted as CD16/32
 
  
 
CD34
 
  
 
c-kit
 
  
 
Sca-1
 
  
 
IL-7R
 
 
 
  
 
cells. Further
division of the CMP population by Flt3 expression was per-
formed by staining the enrichment-sorted lin
 
  
 
c-kit
 
  
 
cells with
anti–CD16/32-FITC, anti–Flt3-PE, anti–c-kit–APC, anti–IL-
7R
 
 
 
–Alexa 594, and anti–Sca-1–Alexa 594, and then sorting for
Flt-3
 
 
 
 CD16/32
 
low 
 
c-kit
 
  
 
Sca-1
 
  
 
IL-7R
 
 
 
  
 
and Flt3
 
  
 
CD16/32
 
low
 
c-kit
 
  
 
Sca-1
 
  
 
IL-7R
 
 
 
  
 
fractions was performed. The BM pro-B
cells were purified by immunomagnetic bead depletion of lineage
marker–positive (except B220
 
 
 
) cells, and then stained with anti–
CD19-FITC, anti–B220-PE, and anti–c-kit–APC, and sorted for
CD19
 
  
 
B220
 
  
 
c-kit
 
  
 
cells. The purity of sorted cells was deter-
mined by reanalyzing a small sample of the collected cells and was
usually 
 
 
 
97%.
 
In Vivo Assays for p-preDC and DC Production by Different Precur-
sor Populations.
 
To examine the capacity for p-preDC and DC
production, purified precursor cells (1–4 
 
  
 
10
 
4
 
) from C57BL
Ly5.2 mice were i.v. injected into lethally irradiated (5.5 Gy
twice with a 3-h interval) C57BL Ly5.1 recipients, along with
5 
 
  
 
10
 
4 
 
recipient type Ly 5.1 unfractionated BM cells to ensure
mouse survival. At various times after precursor transfer, the thy-
mus and spleens of recipients were collected, and DCs and
p-preDCs were enriched from these tissues by light density separa-
tion and then immunomagnetic bead depletion using the proce-
dure described elsewhere (26). These DC and p-preDC–enriched
preparations were then stained in four fluorescent colors using
conjugated antibodies to Ly 5.2 to reveal donor-derived cells, to-
gether with conjugated antibodies to other markers expressed by
DCs and p-preDCs. These included pan-DC markers CD11c and
MHC class II, p-preDC marker CD45RA, and DC subset–spe-
cific markers CD4, CD8
 
 
 
, DEC-205, and CD11b. Donor-
derived DCs and p-preDCs were revealed by electronic gating
for Ly5.2
 
  
 
CD45RA
 
  
 
CD11c
 
  
 
and Ly5.2
 
  
 
CD45RA
 
  
 
CD11c
 
int
 
cells, respectively, during flow cytometric analysis. The expres-
sion of other DC markers by these donor-derived cells was fur-
ther analyzed and the proportion of the individual donor-derived
DC subpopulations was then determined.
 
Results
 
Flt3 Expression on BM Cells and on Different Hemopoietic
Progenitor Populations.
 
Based on the fact that both in vivo
and in vitro treatment with Flt3L drastically increase the
number of DCs and p-preDCs in mouse and human (10–T
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15), we proposed that the precursors with the potential to
generate DCs and p-preDCs express the receptor for Flt3L.
Therefore, we examined the surface Flt3 expression on BM
cells and on different defined hemopoietic precursor popu-
lations using multicolor flow cytometric analysis. We used
PE-conjugated anti-Flt3 antibody together with a range of
fluorochrome-conjugated antibodies to other cell surface
markers for distinguishing different hemopoietic cell lin-
eages and different precursor populations. The different he-
mopoietic lineage cells were distinguished as B cells (B220
 
 
 
CD19
 
 
 
), myeloid cells, (Mac-1
 
  
 
Gr-1
 
 
 
), and T cells
(CD3
 
 
 
). For distinguishing the BM precursor populations,
we used the procedures established in the Stanford labora-
tories (29, 30) and in this laboratory (28), which defined
the precursor populations as: multipotent HSCs, Lin
 
 
 
Sca-1
 
  
 
c-kit
 
hi
 
; the CLPs, Lin
 
  
 
IL-7R
 
 
 
  
 
Sca-1
 
lo 
 
c-kit
 
lo
 
; the
CMPs, Lin
 
  
 
IL-7R
 
 
 
  
 
Sca-1
 
  
 
c-kit
 
hi 
 
CD34
 
  
 
CD16/32
 
lo
 
;
and GMPs, Lin
 
  
 
IL-7R
 
 
 
  
 
Sca-1
 
  
 
c-kit
 
hi 
 
CD34
 
 
 
CD16/
32
 
hi
 
. The surface expression of Flt3 on the more commit-
ted precursors for T and B lymphoid cells was also exam-
ined. These precursors were distinguished as: intrathymic
lymphoid precursors (CD4
 
lo 
 
precursors), Lin
 
  
 
CD3
 
  
 
8
 
 
 
25
 
  
 
4
 
lo 
 
Thy-1
 
lo 
 
c-kit
 
 
 
; and BM pro-B cells, Lin
 
  
 
CD19
 
 
 
B220
 
  
 
c-kit
 
 
 
. The results are shown in Fig. 1.
First, the expression of Flt3 by different hemopoietic lin-
eage cells in the BM was examined. Only a small propor-
tion of total BM cells (2.0–2.5%) was found expressing
Flt3, and these Flt3
 
  
 
cells were mainly within the lineage
marker–negative (CD19
 
  
 
Mac-1
 
  
 
Gr-1
 
  
 
CD3 , Lin ) and
MHC class II  cell fraction (Fig. 1 A). In addition, we
found that the majority of the Flt3  BM cells (65–70%) was
within the Lin  c-kit  fraction. Interestingly, a small frac-
tion of these BM Flt3  cells (25–30%) expressed B220 and
relatively lower levels of Flt3 (Fig. 1 A). These Flt3  B220 
cells did not express CD19, MHC class II, Mac-1, Gr-1,
and c-kit (unpublished data), indicating that they were nei-
Figure 1. Surface expression
of Flt3 by mouse BM cells and
by different hemopoietic precur-
sor populations. Total BM cells
were stained with PE-conju-
gated anti-Flt3 antibody together
with other fluorescence-conju-
gated antibodies against different
surface molecules expressed by
BM cells including CD19, B220,
CD3, Mac-1, Gr-1, MHC class
II, and c-kit. The expressions of
these molecules on the gated
Flt3  BM cells are shown in A.
The solid lines represent the
staining of different surface mol-
ecules and the dashed lines rep-
resent the isotype controls. The
precursor populations from
mouse BM or thymus were first
enriched for lineage marker–
negative cells and then distin-
guished by four color fluores-
cence staining as (B) CLP (c-kit 
CD127 ), (C) CMP (CD34 
CD16/32lo) and GMP (CD34 
CD16/32hi), (D) intrathymic
CD4lo lymphoid precursors (c-kit 
Thy-1lo), and (E) BM pro-B pre-
cursors (c-kit   CD19 ). The
surface expression of Flt3 by
each precursor population was
then examined. The contour
plots display the gating for each
precursor population (cells
within the boxes). The histo-
grams show the Flt3 expression
on each gated precursor popula-
tion. The solid lines represent
the Flt3 staining and the dashed
lines represent the isotype con-
trols. Data presented in this fig-
ure is representative of at least
three similar experiments on
each precursor population.T
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ther B lineage cells nor early precursors. Overall, these re-
sults demonstrated that the BM Flt3  cells were mainly
amongst the Lin  c-kit  precursor populations of the BM.
Because most of the early hemopoietic precursor popu-
lations are within the BM Lin  c-kit  fraction, for further
characterizing these Lin  Flt3  c-kit  BM cells, we also ex-
amined the expression of Flt3 on different early hemopoi-
etic precursor populations. As we expected, the majority
(66–75%) of BM CLPs, the most efficient precursors for
both lymphoid cells and DCs (28, 31), expressed high lev-
els of Flt3 (Fig. 1 B). Interestingly and in contrast, only a
small fraction (22–25%) of the BM CMPs expressed Flt3,
the majority being Flt3  (Fig. 1 C). The more committed
GMPs, the least efficient precursors for DCs (28), did not
express detectable levels of Flt3 on the surface (Fig. 1 C).
When the more committed precursors for T and B lym-
phoid lineages were examined, only 10–13% of the in-
trathymic CD4lo precursors expressed Flt3, and this was a
low level of expression (Fig. 1 D). Only a few pro-B cells
( 3%) expressed low levels of Flt3 (Fig. 1 E). These results
demonstrate that Flt3 was mainly expressed by the early he-
mopoietic progenitors that were not yet restricted to the
development of a single hemopoietic lineage.
The Flt3  BM Cells Contain Precursors for DCs and
p-preDCs. Because Flt3 was expressed by a minor popula-
tion of BM cells as described above, it would be interesting
to test whether these Flt3  BM cells contain precursors for
DCs and p-preDCs. Therefore, we tested Flt3  and Flt3 
fractions of BM cells for their DC and p-preDC precursor
activity. The Flt3  and Flt3  populations were purified
from the BM of Ly5.2 mice and transferred (2–5   104) i.v.
together with the host-type BM cells (5   104) into lethally
irradiated Ly5.1 recipient mice. The Ly5.2  donor-derived
DCs and p-preDCs were then examined at different times
after cell transfer. As shown in Fig. 2 and Table I, both
Flt3  and Flt3  BM cells could generate DCs and p-preDCs
in the recipient spleen 2 wk after cell transfer. However, on
a per cell basis, the Flt3  BM cells were much more effi-
cient (20–30-fold) than the Flt3  BM cell in generating
DCs and p-preDCs (Table I). These results indicated that
the DC and p-preDC precursor activity was enriched in the
Flt3  BM cell fraction. The lower DC and p-preDC pre-
cursor activity of the Flt3  BM cell fraction most likely
originated from the few self-renewable HSCs contained
within the Flt3  fraction (8). Although the Flt3  BM cells
were enriched for DC precursor activity, they could also
generate T cells, B cells, and myeloid cells (unpublished
data) and therefore were not DC-restricted precursors.
Because a small fraction of the Flt3  BM cells expressed
B220 (Fig. 1 A), we also tested the Flt3  B220  and the
Flt3  B220  populations, respectively, for their capacity to
produce DCs. As shown in Table I, both B220  and
B220  fractions of the Flt3  BM cells contained precursors
of DCs. However, the Flt3  B220  cells were more effi-
cient than the Flt3  B220  cells in generating DCs (Table
I). In addition to DCs, the Flt3  B220  cells were also
able to produce other hemopoietic cell lineages including
B cells, T cells, and myeloid cells, whereas the Flt3 
B220  cells only produced a few B cells and myeloid cells
(unpublished data).
The results shown above, together with the finding that
the majority of the Flt3  B220  cells was also Lin  c-kit 
(Fig. 1 A), suggest that the DC precursors were mainly con-
tained within the Lin  Flt3  B220  c-kit  BM precursor
population. Because most of the early hemopoietic precur-
Figure 2. Generation of DCs by BM Flt3  and Flt3  cell populations.
BM cells from Ly5.2 mice were stained with PE-conjugated Flt3 anti-
body. The Flt3  and Flt3  cell fractions were purified by cytometric sort-
ing. The purified cells were then i.v. transferred into lethally irradiated
Ly5.1 recipient mice. The generation of DCs in the spleen of recipient
mice was examined 2 wk after cell transfer. The donor-derived DCs were
distinguished as Ly5.2  CD11c  cells from the DC-enriched spleen cell
preparation. The data presented is typical of two such experiments.
Table I. Numbers of DCs Generated by Flt3  and Flt3  BM
Cell Populations
Precursor populations (104)
Flt3 
BM
Flt3 
BM
Flt3 
B220 
Flt3 
B220 
Splenic DCs
( 103) 6.3–12.4 227.2–262.6 21.0–27.9 278.7–321.3
Splenic p-preDCs
( 103) 5.0–7.5 103.1–148.5 19.4–25.2 124.0–179.3
The precursor populations were purified by FACS®  sorting and
transferred i.v. into the irradiated Ly 5.1 recipient mice. 2 wk after
precursor transfer, the recipient spleens were analyzed for donor-derived
DCs and p-preDCs. The data presented are the ranges of donor-derived
DC and p-preDC numbers generated by 104  transferred BM cell
populations from two experiments. Each experimental group contained
two to three recipient mice.T
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sor populations (including CLP, CMP, and GMP) are
within the Lin  c-kit  fraction of the BM and some of these
precursors expressed surface Flt3 (Fig. 1, B and C), we ex-
amined the possible correlation of Flt3 expression with the
capacity to generate DCs by these precursor populations.
DC Precursor Activities Are Enriched in the Flt3  Fraction of
CMPs. As described above, the BM CMP population ap-
peared to be heterogeneous and separable into two frac-
tions based on the surface expression of Flt3. Because pre-
vious studies (28, 31, 32) have shown that CMPs are able
to generate DCs in vivo, it therefore became interesting to
examine which of these CMP fractions contained the DC
precursor activity. To test this, the Flt3  and Flt3  fractions
of CMPs were first purified and sorted from the BM of
Ly5.2 mice. A purity of 97–98% was obtained. The puri-
fied precursor populations (1–3   104) together with host-
Figure 3. Generation of DCs and other
hemopoietic lineage cells by Flt3  and Flt3 
fractions of CMPs. The Flt3  and Flt3 
fractions of CMPs were purified from the
BM of Ly5.2 mice and i.v. transferred to le-
thally irradiated Ly5.1 recipient mice. The
donor-derived cells were distinguished as
Ly5.2  cells. For DC production, recipient
spleens were analyzed 2 wk after precursor
transfer. Donor-derived DCs were identi-
fied as Ly5.2  CD11c  cells from DC-
enriched spleen cell preparations (A). The
subsets of donor-derived DCs were further
segregated by their expression of CD4 and
CD8 (A). For myeloid cell production, the
recipient BM cells were analyzed 1 wk after
precursor transfer for donor-derived Ly5.2 
Mac-1  Gr-1  cells (B). For B cell and T
cell production, the recipient spleen and
thymus were analyzed 2 wk after precursor
transfer for donor-derived Ly5.2  B220  or
Ly5.2  CD4  cells (B). The data presented
is typical of three such experiments. Each
experimental group contained two to three
recipient mice.T
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type BM cells (5   104) were injected i.v. into lethally irra-
diated Ly5.1 recipient mice. The Ly 5.2  DC generated
from the Flt3  and Flt3  CMP fractions was examined at
different times after injection. As shown in Fig. 3 A and
Table II, the minor Flt3  fraction of CMPs was highly effi-
cient in DC production. In contrast, the major Flt3  CMPs
produced only a small number of DCs, although it retained
ability to produce granulocytes and macrophages (Fig. 3 B
and Table II). Similar results were obtained from all the
time points analyzed (unpublished data). These observa-
tions indicated that the DC precursor activity of CMPs was
highly enriched in the Flt3  fraction, whereas the Flt3 
CMPs had very poor DC precursor activity.
To determine whether the differences in DC precursor
activity between the Flt3  and Flt3  fractions of CMPs
were simply quantitative, or whether there was segregation
of the precursors for different DC subpopulations, we fur-
ther analyzed the types of DCs generated. As shown in Fig.
3 A, 2 wk after injection, all three DC populations identi-
fied in mouse spleen, namely the CD4  8 , CD4  8 , and
CD4  8  DCs, were found within the large number of
DCs generated from Flt3  CMPs as well as within the very
small number of DCs generated from Flt3  CMPs.
The Flt3  CMP Contains Precursors for Both B Lineage Cells
and Myeloid Cells. It has been reported that although most
of the cells within the CMP fraction are myeloid-restricted
precursors, some residual B cell precursor activity can still
be detected (30). We obtained similar findings. In an at-
tempt to distinguish the cells with B cell precursor activity
from those fully restricted to myeloid development, we
tested the Flt3  and Flt3  fractions of CMPs for precursors
of hemopoietic lineages other than myeloid and DC. The
purified Flt3  and Flt3  CMPs were injected i.v. into le-
thally irradiated Ly 5 disparate recipient mice. The BM of
the recipients was analyzed 1 wk after precursor transfer for
donor-derived myeloid cells, and the thymus and spleen of
the recipient mice were analyzed 2 wk after precursor
transfer for donor-derived T and B lineage cells. These
were determined to be the peak times for the responses an-
alyzed. The results are presented in Fig. 3 B and Table II.
Interestingly, the Flt3  fraction of CMPs displayed an
enriched precursor activity for B lineage cells, but no pre-
cursor activity for T cells was detected (Fig. 3 B and Table
II). In contrast, the Flt3  fraction of CMPs showed no pre-
cursor activities for either B cells or T cells (Fig. 3 B and
Table II). However, both the Flt3  and Flt3  fractions of
CMPs showed precursor activity for granulocytes and mac-
rophages, so there was no segregation of the capacity to
form myeloid cells (Fig. 3 B and Table II). Thus, the origi-
nally described BM CMP was a heterogeneous population,
the Flt3  subgroup of CMPs containing precursors of DCs
and B cells as well as of myeloid cells, whereas only the
Flt3  fraction contained precursors fully committed to my-
eloid development.
The Correlation of DC Precursor Activity with the Level of
Flt3 Expression on Different Precursor Populations. Because
different hemopoietic precursor populations expressed dif-
ferent levels of surface Flt3, it was interesting to determine
if this correlated with their capacity to produce DCs. To
examine this, purified BM CLPs, CMPs (unseparated),
Flt3  CMPs, Flt3  CMPs, GMPs, thymic CD4lo precur-
sors, and BM pro-B cells were transferred i.v. into lethally
irradiated recipients. 2 wk after precursor transfer, the thy-
mus and spleen of the recipient mice were analyzed for do-
nor-derived DCs. As shown in Fig.4, the CLP population,
in which the majority of cells expressed high levels of Flt3,
was the most efficient DC precursor population. Almost all
of the DC precursor activity was within the Flt3  CLP
fraction, whereas the minor Flt3  CLP fraction produced
very few DCs ( 5   103 for 104 transferred Flt3  CLP, in
contrast to 350   103 for the Flt3  CLP) as well as some B
cells, but not myeloid cells (unpublished data), suggesting
that the Flt3  CLP may represent a small fraction of cells at
a relatively later developmental stage within the CLP pop-
ulation. Flt3  CMPs generated DCs with an efficiency that
was lower than that of CLPs, but much higher than the un-
separated CMPs and Flt3  CMPs. GMPs did not express
detectable levels of Flt3 and showed very poor DC precur-
sor activity. A proportion of the thymic CD4lo precursors
expressed low levels of Flt3 and these lymphoid precursors
displayed a lower DC precursor activity than either CLPs
or Flt3  CMPs. Only a few pro-B cells expressed low levels
of Flt3 and these pro-B cells did not show any precursor
activity for DCs. These findings demonstrate a general as-
sociation of Flt3 expression with DC precursor potential.
BM CLPs and the Flt3  Fraction of CMPs Are Potent Pre-
cursors of p-preDCs. The mouse p-preDCs were identi-
fied recently (16, 22–26). However, the early precursors for
these p-preDCs have not yet been identified and character-
ized. Flt3L treatment of mice increased the numbers of
Table II. Numbers of DCs, Myeloid Cells, and Lymphoid Cells 
Generated by Flt3  and Flt3  Fractions of CMPs
Splenic DCs
( 106)
BM
myeloid cells
( 106)
Spleen
B cells
( 106)
Thymic
T cells
( 106)
Flt3 
CMPs
(104) 0.27   0.04 0.26   0.09 3.70   0.50  0.1
Flt3 
CMPs
(104) 0.04   0.01 0.12   0.02  0.1  0.1
The Flt3  and Flt3  fractions of CMPs were purified and i.v. transferred
to lethally irradiated Ly5.1 recipient mice. For DC production by the
precursors, splenic DCs were analyzed 2 wk after precursor transfer. For
myeloid cell production, the BM cells were prepared 1 wk after
precursor transfer from the femoral and tibial bones of the recipient mice
and analyzed for donor-derived Mac-1  and Gr-1  cells. For B cell and
T cell production, the recipient spleen and thymus were analyzed 2 wk
after precursor transfer. The cell numbers presented are the mean  
standard error from three experiments. Each experimental group
contained two to three recipient mice.T
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DCs and p-preDCs in blood and lymphoid tissues (10–16),
and the addition of Flt3L alone efficiently promoted
p-preDC development in mouse BM cultures (20, 21).
These findings suggested that the precursors of p-preDCs
should express the receptor for Flt3L. To test this, purified
BM precursor populations were transferred i.v. into irradi-
ated recipients and the recipient thymus and spleen were
then analyzed for the donor-derived p-preDCs (Ly5.2 
CD11cint  CD45RA ) at different times after precursor
transfer. The peak of p-preDC production was at 2 wk af-
ter transfer. Results at this time point are presented in Figs.
5 and 6 and Table III, but the same relative p-preDC pre-
cursor activity was obtained at 1, 2, and 3 wk after transfer.
BM CLPs, which expressed high levels of Flt3 and were
the most potent precursors for DCs, were also found to be
the most efficient precursors for p-preDCs (Figs. 4 and 5
and Table III). The Flt3  CMPs could also efficiently pro-
duce p-preDCs in both the thymus and spleen of the recip-
ients, although with relatively lower efficiency than the
CLPs, whereas the Flt3  CMPs showed very poor if any
p-preDC precursor activity (Figs. 5 and 6 and Table III).
The more committed myeloid precursor GMP showed al-
most no precursor activity for p-preDCs (Figs. 5 and 6 and
Table III). Nor did BM pro-B cells display any p-preDC
precursor activity. Thus, these BM precursor populations
showed a similar hierarchy of precursor activities for DCs
and p-preDCs, and both were within the Flt3  populations.
The Thymic CD4lo Precursor Population Displays DC but
Not p-preDC Precursor Activity. The results described
above for BM precursor populations suggest that DC and
p-preDC precursor activity resides in the same precursor
populations, both being correlated with populations ex-
pressing surface Flt3. As shown in this and our previous
studies (27, 28), a small proportion of the intrathymic
CD4lo precursors express low levels of Flt3 and this popula-
tion is capable of producing DCs, although with a lower
Figure 4.  Comparison of the generation of DCs by different hemopoi-
etic precursor populations. Different precursor populations were purified
from C57BL/6 Ly5.2  mice by FACS® sorting and transferred i.v. into irra-
diated Ly5.1 recipient mice. 2 wk after precursor transfer, the recipient thy-
mus and spleen were analyzed for donor-derived DCs. Each bar represents
the average DC number produced by 104 precursor cells from three experi-
ments. Each experimental group contained two to three recipient mice.
Figure 5. Generation of p-preDCs by different hemopoietic precursor populations. Different BM precursor populations were purified from C57BL/6
Ly5.2 mice and i.v. transferred to lethally irradiated Ly5.1 recipient mice. 2 wk after precursor transfer, recipient spleens were analyzed for donor-derived
p-preDCs. The DC-enriched cell preparations were stained with anti–Ly5.2-FITC, anti–CD45RA-PE, and anti-CD11c-Alexa 594. The donor-derived
cells were distinguished as Ly5.2  cells (top). The donor-derived p-preDCs were identified as CD45RA  CD11cint cells within the gated Ly5.2  cells
(bottom, cells within the boxes). The data presented is representative of three similar experiments on each precursor population. Each experimental
group contained two to three recipient mice.T
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efficiency than the BM CLPs and the Flt3  CMPs (Fig. 4).
Therefore, we tested whether thymic p-preDCs could also
be generated within thymus by the thymic CD4lo precur-
sors. To our surprise, the thymic CD4lo precursors showed
relatively little precursor activity for either thymic or
splenic p-preDCs (Fig. 6 and Table III), in marked contrast
to their ability to produce DCs (Fig. 4). This marked dif-
ferential in DCs compared with p-preDC production was
sustained at all the time points from 1–3 wk after precursor
transfer (unpublished data).
Discussion
This study was prompted by the finding that the cyto-
kine tyrosine kinase receptor Flt3 is expressed mainly on
early hemopoietic progenitors and that Flt3L promotes the
development of both DCs and p-preDCs. Accordingly, we
examined the expression of Flt3 on the surface of total BM
cells and on different mouse hemopoietic precursor cells,
and then correlated this with their capacity to form DCs
and p-preDCs. The majority of BM Flt3  cells were within
the Lin  c-kit  fraction of BM that contains the established
CLP and CMP populations. Our study showed that the
DC precursor activity was enriched in this Flt3  BM cell
fraction. Our further studies revealed high levels of Flt3 ex-
pression on BM CLPs but a bimodal expression of Flt3 on
CMPs, so the CMPs were not a homogeneous population.
Other downstream precursors had much lower levels of
Flt3 expression.
Our central finding is that these differences in Flt3 ex-
pression show a general correlation with the capacity to
produce DCs and p-preDCs. The point of particular inter-
est is the CMPs, because of the bimodal Flt3 expression
and reports that they could produce both DCs and some B
cells (28, 30–32). In fact, both the B cell and the DC and
p-preDC generation capacity were concentrated in the
minor Flt3  fraction. Thus, the CMP fraction actually had
two distinct components, the major Flt3  fraction was
clearly myeloid restricted and a very poor DC progenitor,
and a minor Flt3  fraction that was oligopotent. It was of
interest that this Flt3  fraction, although unable to form T
cells, was capable of B cell production as well as DC and
p-preDC production, but the efficiency in B cell produc-
tion was  20-fold lower than that of CLPs. Elsewhere we
have shown that thymic DCs and p-preDCs, but not
splenic conventional DCs, do have a lymphoid link in that
they have D-J rearrangements at the IgH gene locus (33).
A developmental linkage of B lineage cells and DCs has
also been suggested (34). However, the DC precursor ac-
tivity appears to branch off before the pro-B cells stage.
Consistent with this, we found that the Flt3  pro-B cells
were completely devoid of a capacity to form either DCs
or p-preDCs, suggesting that the p-preDC precursor ac-
Figure 6. Comparison of the generation of p-preDCs by different he-
mopoietic precursor populations. Different precursor populations were
purified from C57BL/6 Ly5.2  mice by FACS® sorting and transferred
i.v. into irradiated Ly5.1 recipient mice. 2 wk after precursor transfer, the
recipient thymus and spleen were analyzed for donor-derived p-preDCs.
Each bar represents the average number of p-preDCs produced by 104
precursor cells from three experiments. Each experimental group con-
tained two to three recipient mice.
Table III. Generation of p-preDCs by Different Precursor Populations
Precursor population (104)
CLP Flt3  CMP Flt3  CMP GMP Thymic CD4lo Pro-B
Thymic p-preDCs
( 103) 1.60   0.15 0.55   0.08 0.20   0.01 0.03   0.01 0.22   0.05  0.1
Splenic p-preDCs
( 103) 75.7   1.75 49.0   8.20 2.81   0.45 0.80   0.08 2.21   0.35  0.1
The precursor populations were purified by FACS® sorting and transferred i.v. into the irradiated Ly 5.1 recipient mice. 2 wk after precursor transfer,
the recipient thymus and spleen were analyzed for donor-derived p-preDCs. The numbers of p-preDCs presented are the mean   standard error
from three experiments. Each experimental group contained two to three recipient mice.T
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tivity also branches off between the stages of CLPs to
pro-B cells.
It was interesting that the ability of BM precursors to
form both DCs and p-preDCs cut across the myeloid ver-
sus lymphoid precursor segregation. In fact, DC precursor
potential was best defined by the levels of expression of
Flt3 rather than the established myeloid or lymphoid pre-
cursor makers. At this level the same precursor in BM gen-
erates all DC subtypes and p-preDCs, with similar kinetics.
However, a separation of the pathways leading to thymic
DCs and thymic p-preDCs has clearly occurred at some
point downstream because the earliest T precursor within
the thymus, the “lymphoid-restricted” CD4lo precursor, re-
tains a capacity to form DCs but has very little capacity to
form p-preDCs. It is not clear whether this separation of
pathways occurred before or after thymus seeding.
Interestingly, in this study we found that a small propor-
tion of the Flt3  BM cells also expressed B220 and low lev-
els of CD11c (unpublished data), but was negative for
CD19, MHC class II, and c-kit, a phenotype similar to that
of recently described “common DC precursors” in mouse
blood (35). However, the DC precursor activity of this
Flt3  B220  population was much lower than that of other
Flt3  BM precursor populations. These cells could also
generate some B cells and a few myeloid cells upon i.v.
transfer (unpublished data) and therefore were not DC-
restricted precursors. Whether this cell population contains
separate precursors for DCs, B cells, and myeloid cells is yet
to be clarified. We could not exclude the possibility that
this cell population also includes some already formed
B220  CD11clo p-preDCs. Currently, the relationship of
this BM Lin  Flt3  B220  precursor population to the
blood common DC precursors remains unclear.
Overall, our study suggests a distinct developmental
pathway for DCs and p-preDCs, with the precursors in
BM defined by the surface expression of Flt3 (Fig. 7).
However, the developmental pathways leading to both
DCs and p-preDCs downstream of these early Flt3  BM
precursors remain to be mapped. In particular, the relation-
ship of these early Flt3  DC and p-preDC precursors to the
recently described “common DC precursors” (35) or to
“preimmunocytes” (22) is yet to be clarified.
Figure 7. The proposed developmental pathways for DCs and p-preDCs. Both conventional DCs and p-preDCs can develop from BM Flt3  pre-
cursors regardless of whether this involves the “myeloid pathway” or the “lymphoid pathway.” The relationship of the Flt3  lymphoid or myeloid pre-
cursors to the recently described common DC precursors currently remains unknown. HSC, hemopoietic stem cells; HPC, multipotent hemopoietic
progenitor cells; CLP, common lymphoid precursors; CMP, common myeloid precursors; GMP, granulocyte and macrophage precursors; pro-T, in-
trathymic CD4lo precursors; pro-B, B220  CD19  c-kit  B cell precursors. The most efficient precursors of DCs and p-preDCs are the Flt3-expressing
BM precursors, shown as cells within the boxes. The thickness of the lines is relative to the efficiency of the precursors in producing DCs or p-preDCs.
The dashed lines represent proposed developmental pathways yet to be confirmed by direct evidence.T
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